Market Performance - On January 26, A-shares experienced a collective adjustment, with the Shanghai Composite Index falling by 0.09% to 4132.61 points, the Shenzhen Component Index dropping by 0.85% to 14316.64 points, and the ChiNext Index decreasing by 0.91% to 3319.15 points [1] Fund Manager Changes - From January 24 to January 26, a total of 39 fund managers underwent changes, with 544 fund products experiencing manager departures in the past 30 days [3] - The reasons for the changes included 18 managers leaving due to job changes, 2 due to personal reasons, and 1 due to the end of an agency role [3] - Notably, 47 fund products announced new fund manager appointments during the same period, involving 20 different managers [5] Fund Manager Performance - Fund manager Xu Yizun currently manages assets totaling 54.60 billion yuan, with the highest return product being the Huatai-PineBridge CSI 500 Index Enhanced A, which achieved a return of 132.77% over 10 years and 66 days [5] Fund Research Activity - In the past month (December 27 to January 26), Bosera Fund conducted the most company research, engaging with 46 listed companies, followed by Huaxia Fund with 43 and Southern Fund with 36 [6][7] - The chemical products industry was the most researched sector, with 196 instances, followed by the automotive parts industry with 179 instances [6][7] Individual Stock Research - The most researched stock in the past month was Dajin Heavy Industry, with 67 fund management companies participating in the research, followed by Chaojie Co. and Haitan Ruisheng, each with 57 [8][9] - In the last week (January 19 to January 26), Dajin Heavy Industry remained the top focus, with the same number of fund institutions involved [8][9]

汇添富中证A500指数量化增强型证券投资基金（以下简称"本基金"）的募集已获中国证监会证监许可 [2025]2044号文注册。中国证监会对本基金募集的注册，并不表明其对本基金的投资价值、市场前景和 收益作出实质性判断或保证。 本基金的基金类型为股票型证券投资基金，运作方式为契约型开放式。 1、本基金的基金管理人为汇添富基金管理股份有限公司（以下简称"本公司"），基金托管人为中国农 业银行股份有限公司，登记机构为汇添富基金管理股份有限公司。 2、本基金募集期限自2026年2月2日起至2026年2月27日。 登录新浪财经APP 搜索【信披】查看更多考评等级 重要提示 本基金认购将通过本公司的直销中心、线上直销系统以及其他销售机构的销售网点公开发售。其中，本 基金A类基金份额通过本公司直销机构（含直销中心和线上直销系统）和其他销售机构公开发售。本基 金C类基金份额在认购阶段暂不开通直销机构（含直销中心、线上直销系统）发售渠道，投资者在认购 阶段如需选择C类基金份额的，可通过其他销售机构进行认购。本基金C类基金份额后续在直销机构上 线的具体情况将另行公告。 3、本基金的发售对象为符合法律法规规定的可投资于证券投资基金 ...

公告送出日期：2026年01月24日 1公告基本信息 3离任基金经理的相关信息 ■ 4其他需要说明的事项 本公司已就上述事项在中国证券投资基金业协会完成相关手续。 汇添富基金管理股份有限公司 2026年01月24日 ■ 2新任基金经理的相关信息 ■■ ...

一审法院认为,被告某银行锦州分行系案涉"汇添富稳健添盈一年持有期混合型证券投资基金"的代销 机构，原告王某通过被告购买上述理财产品,双方构成金融服务法律关系。 中国经济网北京1月23日讯 信网/信号新闻21日报道《推销基金时未充分告知风险光大银行锦州分 行被判承担客户一半损失》显示，王女士在中国光大银行股份有限公司锦州分行（以下简称"光大银行 锦州分行"）理财经理的推荐下，投入600万元购买了一款中风险基金，后续分两次赎回，但第二次赎 回时本金部分产生了14万余元的亏损，于是将光大银行锦州分行告上法庭。 近日，信号新闻获悉，一审法院审理后认为，光大银行锦州分行在销售该理财产品过程中，未对客 户进行书面风险告知、未履行风险评估义务，对客户投资损失存在过错，需承担50%本金损失的赔偿 责任。光大银行锦州分行提起上诉，被二审法院驳回。 裁判文书网发布的《辽宁省锦州市中级人民法院民事判决书》（（2025）辽07民终1743号）显 示，一审法院查明事实如下： 原告王某多次在被告某银行锦州分行购买金融理财产品，被告为原告指定专属理财经理裴超。被告 某银行锦州分行于2020年4月7日对原告王某进行购买理财产品进行了风险评估 ...

Core Viewpoint - The case highlights the responsibility of financial institutions in providing adequate risk disclosures and assessments to clients when selling investment products, as demonstrated by the court's ruling against China Everbright Bank's Jinzhou branch for failing to inform the client about the risks associated with the investment product [1][3]. Group 1: Case Details - Ms. Wang invested 6 million yuan in a medium-risk fund recommended by a financial manager at China Everbright Bank's Jinzhou branch, leading to a loss of over 140,000 yuan upon redemption [1][2]. - The court found that the bank did not conduct a written risk assessment or adequately inform Ms. Wang about the product's risks, resulting in a ruling that the bank must compensate 50% of the principal loss [3]. Group 2: Regulatory Compliance - The bank's failure to provide written risk disclosures and timely updates on product performance during the investment period was a key factor in the court's decision [3]. - The testing of the bank's mobile app revealed that clients could purchase higher-risk products despite having a lower risk tolerance, raising questions about compliance with the "suitability" principle in financial product sales [4][5]. Group 3: Legal and Industry Implications - Legal experts emphasize that financial institutions must adhere to strict sales processes, including comprehensive risk assessments and clear written disclosures to clients [6]. - The ruling serves as a warning to the banking industry to ensure compliance with regulatory standards and to improve operational procedures in the sale of financial products [6].

Group 1 - Yao Pi Glass experienced a 5.06% increase in stock price, reaching 8.93 CNY per share, with a trading volume of 112 million CNY and a turnover rate of 1.72%, resulting in a total market capitalization of 8.722 billion CNY [1] - The company, Shanghai Yao Pi Glass Group Co., Ltd., was established on November 23, 1993, and listed on January 28, 1994. Its main business involves the production and sale of transparent float glass, colored float glass, and related deep-processing products [1] - The revenue composition of Yao Pi Glass includes automotive processed glass at 38.72%, building processed glass at 35.22%, float glass at 32.77%, and other sources at 1.70% [1] Group 2 - Among the top ten circulating shareholders of Yao Pi Glass, a fund under Huatai-PineBridge ranked first. The CSI Shanghai State-Owned Enterprises ETF (510810) reduced its holdings by 330,000 shares, now holding 2.4738 million shares, which represents 0.26% of the circulating shares [2] - The CSI Shanghai State-Owned Enterprises ETF (510810) was established on July 28, 2016, with a latest scale of 6.747 billion CNY. Year-to-date returns are 3.61%, ranking 3735 out of 5546 in its category; the one-year return is 21.79%, ranking 3346 out of 4261; and since inception, the return is 9.11% [2] Group 3 - The fund manager of the CSI Shanghai State-Owned Enterprises ETF (510810) is Wu Zhenxiang, who has a cumulative tenure of 15 years and 356 days. The total asset scale of the fund is 18.598 billion CNY, with the best fund return during his tenure being 208.83% and the worst being -31.53% [3]

Group 1: Aviation ETF Fund Overview - The Aviation ETF Fund (159257) focuses on low-altitude economy, military industry, and commercial aerospace, with the defense industry being the largest weighted sector at 61.6% [9] - The fund's index includes significant exposure to low-altitude economy stocks, accounting for 53% of the index, with eight of the top ten constituent stocks being low-altitude economy concept stocks [12][14] - The commercial aerospace sector represents 30% of the fund, covering satellite navigation and satellite internet, which positions it to capitalize on the trillion-dollar market opportunities in the satellite industry [14] Group 2: Market Trends and Performance - The constituent stocks of the Aviation ETF Fund have shown strong performance, with notable increases such as Zhongke Xingtu rising over 11% and Tianyin Electromechanical increasing by over 9% [3] - The commercial aerospace market is experiencing significant growth, driven by strong policy support and improving profitability, similar to trends observed in the renewable energy sector [6][7] - The global aerospace economy is projected to reach $1.8 trillion by 2035, with commercial aerospace contributing significantly to this growth [8] Group 3: IPO Developments - Blue Arrow Aerospace has entered the inquiry stage for its IPO on the Sci-Tech Innovation Board, alongside several other commercial aerospace startups expected to complete their IPO counseling by the second half of 2025 [2] Group 4: SpaceX and Industry Dynamics - SpaceX is advancing its IPO plans with a target to complete it by July this year, aiming for a valuation of approximately $1.5 trillion, while also planning to launch a second-generation Starlink satellite communication system by 2027 [4][7] - The commercial aerospace sector is becoming a focal point in global technological competition, with both the U.S. and China investing heavily in their respective aerospace initiatives [7]

Core Viewpoint - The A-share market experienced fluctuations on January 22, with the Shanghai Composite Index rising by 0.14%. The innovative drug sector faced pressure, as evidenced by the decline of the Science and Technology Innovation Drug ETF Huatai (589120) by 1.51% by 15:00. However, the ETF saw a net inflow of funds totaling 27.7361 million yuan over the past three days, indicating a trend of buying on dips [1]. Group 1: Market Performance - The Science and Technology Innovation Drug ETF Huatai (589120) recorded a net inflow of 27.7361 million yuan over three days, showing a clear trend of increased buying despite market declines [1]. - By 15:00, the ETF's component stocks exhibited mixed performance, with notable gains from Kangxinuo at 1.81%, Baiaotai at 0.49%, and Haoyuan Pharmaceutical at 0.48%. Conversely, Yifang Bio fell over 6%, Rongchang Bio dropped over 4%, and Baili Tianheng decreased by over 3% [6]. Group 2: Industry Insights - According to the National Medical Insurance Administration, 76 innovative drugs are expected to be approved for market entry by the National Medical Products Administration by 2025, marking a record high and indicating a trend towards diversified innovative therapies in China [4]. - Donghai Securities predicts that the innovative drug sector is entering a new era, transitioning from a generics-dominated market (pre-2018) to a period of transformation (2018-2025) characterized by price reductions and increased R&D investments in innovative drugs. By 2026, innovative drugs are expected to dominate the pharmaceutical industry in China, supported by complementary insurance policies and a focus on the pace of new drug launches and competitive dynamics [5].

责任编辑：卢昱君 香港联交所最新数据显示，1月16日，汇添富基金管理股份有限公司减持三生制药（01530）178.45万 股，每股作价26.4494港元，总金额约为4719.9万港元。减持后最新持股数目约为1.51亿股，最新持股比 例为5.93%。 责任编辑：卢昱君 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 香港联交所最新数据显示，1月16日，汇添富基金管理股份有限公司减持三生制药（01530）178.45万 股，每股作价26.4494港元，总金额约为4719.9万港元。减持后最新持股数目约为1.51亿股，最新持股比 例为5.93%。 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源 | 野马财经 作者 | 李白玉 图源：罐头图库 硬件确定性+软件潜力 AI产业双轮驱动增长 当前，AI产业的双轮驱动格局日益清晰。算力基础设施建设和智能终端普及为AI技术落地提供了坚实 基础，而大模型技术突破和算法创新正在释放AI的应用潜力，构成AI产业增长的内在动力机制。 从硬件侧来看，AI硬件领域正迎来前所未有的增长周期，其确定性源于大模型技术演进对算力需求的 指数级增长。随着大模型参数量从亿级向万亿级跨越，AI训练和推理所需的计算资源呈几何级数增 加。 据摩根大通分析，本轮始于2024年的AI硬件上行周期，非常有可能延续至2026年，甚至是2027年。一 方面，人工智能应用仍在快速扩张，主要应用的Token处理量较2023年增长达到5至10倍。另一方面，大 型科技企业持续投入资金以支持技术发展的意愿依然强烈。需求增长轨迹保持稳定，而供应端响应却相 对滞后，在芯片、电力等关键资源领域形成供给瓶颈。 人工智能产业爆发，普通人如何共享发展成果？ 当前，全球人工智能产业正处在高速发展阶段，重塑全球产业格局，成为推动社会进步的重要力量 ...